The AE889 and AI500 antibodies recognize Klebsiella pneumoniae surface antigens by flow cytometry

Authors

  • Xenia Crespo-Yanez
  • Imen Ayadi

DOI:

https://doi.org/10.24450/journals/abrep.2021.e570

Abstract

The recombinant antibodies AE889 and AI500 bind to the surface of the K. pneumoniae 52145 strain as detected by flow cytometry; AI144, AI501, AI502, AI505 and AS733 antibodies do not.

Introduction

Klebsiella pneumoniae 52145 strain is a Gram-negative bacterium classified as one of the ESKAPE pathogens, which are drug-resistant and responsible for nosocomial infections (Rice, 2008). Here, we demonstrate the ability of the recombinant antibodies AE889 and AI500 (but not AI144, AI501, AI502, AI505 and AS733) to detect live K. pneumoniae 52145 strain by flow cytometry.

Materials & Methods

Antibodies: ABCD_AE889, ABCD_AI144, ABCD_AI500, ABCD_AI501, ABCD_AI502, ABCD_AI505 and ABCD_AS733 antibodies (ABCD nomenclature, http://web.expasy.org/abcd/) were produced by the Geneva Antibody Facility (http://unige.ch/medecine/antibodies/) as mini-antibodies with the antigen-binding portion fused to a rabbit IgG2 Fc. The synthesized scFv sequences (Twist Bioscience) correspond to the sequences of the variable regions joined by a peptide linker (GGGGS)3 (see Table 1 for clone names and references). HEK293 suspension cells (growing in FreeStyle™ 293 Expression Medium, Gibco 12338) were transiently transfected with the vector coding for the scFv-Fc of each antibody. Supernatants (see Table 1 for individual yields) were collected after 4 days.

ABCD Target References Yield (mg/L)
AE889 CPS K30 and K33 Goñi et al., 1983 20
AI144 Citrate-sodium symporter Frey et al., 2008 100
AI500 LPS O1 serotype Szijárto et al., 2017 90
AI501 K antigen, CPS Diago-Navarro et al., 2017 30
AI502 K antigen, CPS Diago-Navarro et al., 2017 20
AI505 LPS O3 serotype Rollenske et al., 2018 50
AS733 Fimbrial subunit type 3 Wang et al., 2019 70
Table 1. Clone number, epitope, reference and production yields for the antibodies used in this study.

Antigen: The Kp52145 strain is a clinical K. pneumoniae isolate (serotype O1:K2, sequence type 66) (Nassif and Sansonetti, 1986). K. pneumoniae 52145 was cultivated overnight at 37 °C in 3 mL of LB medium (Froquet et al., 2009).

Protocol:1 mL of bacterial culture were centrifuged for 3 min at 4500 rpm. Bacteria were resuspended in 1 mL of SBS buffer (2 mM Na2HPO4 2H2O, 14.7 mM KH2PO4, 100 mM sorbitol, pH 6.0) and pelleted again. All subsequent steps were performed in SBS buffer. Bacteria were resuspended in 1 mL of buffer and diluted 1/100. 200 μL of diluted bacteria were incubated for 10 min with 2 μg/L of primary antibody at room temperature and under agitation. Bacteria were then centrifuged, washed with 1 mL of buffer, resuspended in 400 μL, then incubated with an Alexa 488-coupled goat anti-rabbit IgG (Life Technologies A-11008, diluted 1/200) for 20 min. Bacteria were washed once with 1 mL of buffer and resuspended in 400 μL before analysis by flow cytometry (BD LSRFortessa Cell Analyzer, 647800E6).

Results

Bacteria incubated with AE889 and AI500 exhibited a clear fluorescent signal compared to negative control, where no primary antibody was used (Fig. 1, No primary antibody). Since Kp52145 bacteria belong to the O1 serotype (Nassif and Sansonetti, 1986), we also used as a negative control AI505, an antibody that recognizes the K. pneumoniae LPS O3 serotype (Fig. 1). Antibodies AI144, AI501, AI502 and AS733, as well as the negative control AI505, did not measurably bind live K. pneumoniae 52145 (Fig. 1). The same antibodies were tested against K. pneumoniae strains KpGe (Lima et al., 2018) and LM21 (Favre-Bonte et al., 1999), following the same protocol. Antibodies AI144, AI501, AI502, AI505, AS733 and AE889 did not measurably bind KpGe strain. K. pneumoniae LM21 incubated with AS733 exhibited a clear fluorescent signal compared to the negative control (no primary antibody), whereas antibodies AI144, AI501, AI502, AI505 and AE889 did not measurably bind the live bacteria (data not shown).

Figure 1. Live K. pneumoniae 52145 are coated with AI500 and AE889, as detected by flow cytometry. Graphs depict the Alexa Fluor 488 signal (Fluorescence axis) vs. the number of events (Cell number axis). AI500 and AE889 bound specifically to Kp52145 bacteria; AI501, AI502, AI144, AS733 and the negative control AI505 did not. No labelling was seen when the primary antibody (No primary antibody) was omitted.

Conflict of interest

The authors declare no conflict of interest.

References

Diago-Navarro E, Calatayud-Baselga I, Sun D, et al. Antibody-based immunotherapy to treat and prevent infection with hypervirulent Klebsiella pneumoniae. Clin Vaccine Immunol. 2017; 24(1):e00456-16. PMID: 27795303.

Favre-Bonte S, Joly B, Forestier C. Consequences of reduction of Klebsiella pneumoniae capsule expression on interactions of this bacterium with epithelial cells. Infect Immun. 1999; 67(2):554-61. PMID: 9916058.

Frey D, Huber T, Plückthun A, Grütter MG. Structure of the recombinant antibody Fab fragment f3p4. Acta Crystallogr D Biol Crystallogr. 2008; 64:636-43. PMID: 18560151.

Froquet R, Lelong E, Marchetti A, Cosson P. Dictyostelium discoideum: a model host to measure bacterial virulence. Nat Protoc. 2009; 4(1):25-30. PMID: 19131953.

Goñi F, Frangione B. Amino acid sequence of the Fv region of a human monoclonal IgM (protein WEA) with antibody activity against 3,4-pyruvylated galactose in Klebsiella polysaccharides K30 and K33. Proc Natl Acad Sci U S A. 1983; 80(15):4837-41. PMID: 6410398.

Lima WC, Pillonel T, Bertelli C, Ifrid E, Greub G, Cosson P. Genome sequencing and functional characterization of the non-pathogenic Klebsiella pneumoniae KpGe bacteria. Microbes Infect. 2018; 20(5):293-301. PMID: 29753816.

Nassif X, Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun. 1986; 54(3):603-8. PMID: 2946641.

Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008; 197(8):1079-81. PMID: 18419525.

Rollenske T, Szijarto V, Lukasiewicz J, et al. Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen. Nat Immunol. 2018;19(6):617-624. PMID: 29760533.

Szijárto V, Nagy G, Guachalla L, et al. Anti-galactan II monoclonal antibodies targeting Klebsiella pneumoniae. Austria/Germany; WO2018029356, 2017.

Wang Q, Rajan S, Chang C, et al. MrkA polypeptides, antibodies, and Uses Thereof. USA; US20190062411, 2019.

Downloads

Published

2021-11-10

Section

Article

How to Cite

1.
Crespo-Yanez X, Ayadi I. The AE889 and AI500 antibodies recognize Klebsiella pneumoniae surface antigens by flow cytometry. Antib. Rep. [Internet]. 2021 Nov. 10 [cited 2024 Nov. 24];4(2):e570. Available from: https://oap.unige.ch/journals/abrep/article/view/570